Cytosine-beta-D-arabinofuranoside
Common Name: |
Cytosine-beta-D-arabinofuranoside |
IUPAC Name: |
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Molecular Formula: |
C9H13N3O5 |
SMILES: |
C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O |
Inchi: |
1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16) |
Inchi Key: |
UHDGCWIWMRVCDJ-UHFFFAOYSA-N |
Cas No: |
7428-39-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
243.22 |
Mass (g/mol) |
243.086 |
Molar Refractivity |
55.85 |
Net Charge |
|
HBD |
4 |
HBA |
6 |
Rt Bonds |
2 |
Rings |
2 |
TPSA |
130.83 |
Hetero Atoms |
8 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
212.5 |
Boiling Point (°C@760.00mm Hg) |
545.68 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.56 |
LogP |
-2.563 |
iLOGP |
0.32 |
XLOGP3 |
-2.13 |
WLOGP |
-2.88 |
MLOGP |
-2.29 |
ESOL Log S |
-0.14 |
ESOL Solubility (mg/ml) |
178 |
ESOL Solubility (mol/l) |
0.732 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.09 |
Ali Solubility (mg/ml) |
198 |
Ali Solubility (mol/l) |
0.82 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
1.01 |
Silicos-IT Solubility (mg/ml) |
2490 |
Silicos-IT Solubility (mol/l) |
10.2 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-9.30 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.351 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.326 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Danger |
Eye Irritation |
0 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |